# AAV2-GDNF for Advanced Parkinson s Disease

> **NCT01621581** · PHASE1 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 25 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **GENETIC:** Convection enhanced delivery/AAV2-GDNF

## Key facts

- **NCT ID:** NCT01621581
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-13
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621581, "AAV2-GDNF for Advanced Parkinson s Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01621581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*